Rxsight Inc reports results for the quarter ended in March - Earnings Summary

RxSight

10/05/2023 12:18

* Rxsight Inc  RXST.OQ  reported a quarterly adjusted loss
of 42
cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 53
cents per share.
    * Revenue rose 95.6% to $17.49 million from a year ago;
analysts
expected $16.28 million. 
    * Rxsight Inc's reported EPS for the quarter was a loss
of 42
cents​.
    * The mean earnings estimate of analysts had risen by
about 11.6%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Rxsight Inc shares had risen by 15.4% this quarter and
gained 51.9% so far this year.
    * The company reported a quarterly loss of $13.21 million.
    * Wall Street's median 12-month price target for Rxsight Inc
is
$24.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 11:17 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.53          -0.42          Beat
 Dec. 31 2022      -0.75          -0.56          Beat
 Sep. 30 2022      -0.71          -0.61          Beat
 Jun. 30 2022      -0.69          -0.61          Beat